Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
The AGO2 adaptor LIMD1 expands the functional and evolutionary reach of microRNA targeting.
Journal: Science advances
Published: July 23, 2026
Clonal LIMD1 loss drives PD-L1 immune evasion via ARIH1-dependent ubiquitination in lung cancer.
Journal: Life science alliance
Published: June 11, 2026
Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays.
Journal: NPJ precision oncology
Published: February 25, 2023
Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effectiveness in frontline treatment of advanced stage endometrial cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: February 07, 2023
Frailty in the ICU: what are we doing with all this information?
Journal: Intensive care medicine
Published: June 09, 2022
Patient with Lobular Carcinoma of the Breast and Activating AKT1 E17K Variant.
Journal: Acta medica academica
Published: February 24, 2021
Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes.
Journal: Cell death & disease
Published: February 18, 2021
A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia.
Journal: EMBO molecular medicine
Published: June 23, 2018
miR-132 suppresses transcription of ribosomal proteins to promote protective Th1 immunity.
Journal: EMBO reports
Published: June 20, 2018
MicroRNA-155 induction via TNF-α and IFN-γ suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells.
Journal: The Journal of biological chemistry
Published: July 27, 2017
Last Updated: 09/26/2026